Talnetant Uses, Dosage, Side Effects and more
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.
| Trade Name | Talnetant |
| Generic | Talnetant |
| Talnetant Other Names | Talnetant |
| Type | |
| Formula | C25H22N2O2 |
| Weight | Average: 382.4544 Monoisotopic: 382.168127958 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in schizophrenia and schizoaffective disorders, irritable bowel syndrome (IBS), and chronic obstructive pulmonary disease (COPD).
